Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Reports Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning.

Sort by


Microbiotix, Inc. - Product Pipeline Review - 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Microbiotix, Inc. - Product Pipeline Review - 2016’, provides an overview of the Microbiotix, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Microbiotix, Inc...
$ 1,500.00 Read More

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2016’, provides an overview of the Neuromyelitis Optica (Devic’s Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neurom...
$ 2,000.00 Read More

Arterial Thrombosis - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2016’, provides an overview of the Arterial Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arterial Thrombosis, complete with analysis...
$ 2,000.00 Read More

AbbVie Inc. - Product Pipeline Review - 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘AbbVie Inc. - Product Pipeline Review - 2016’, provides an overview of the AbbVie Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by AbbVie Inc., complete with a...
$ 1,500.00 Read More

Glomerulonephritis - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Glomerulonephritis - Pipeline Review, H1 2016’, provides an overview of the Glomerulonephritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Glomerulonephritis, complete with analysis by...
$ 2,000.00 Read More

Visceral Pain - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Visceral Pain - Pipeline Review, H1 2016’, provides an overview of the Visceral Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Visceral Pain, complete with analysis by stage of devel...
$ 2,000.00 Read More

Endometriosis - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2016’, provides an overview of the Endometriosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endometriosis, complete with analysis by stage of devel...
$ 2,000.00 Read More

Pulmonary Arterial Hypertension - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Pulmonary Arterial Hypertension - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Arterial Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hyp...
$ 2,000.00 Read More

Poxvirus Infections - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Poxvirus Infections - Pipeline Review, H1 2016’, provides an overview of the Poxvirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Poxvirus Infections, complete with analysis...
$ 2,000.00 Read More

Myocarditis - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Myocarditis - Pipeline Review, H1 2016’, provides an overview of the Myocarditis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocarditis, complete with analysis by stage of development, ...
$ 2,000.00 Read More

Tinnitus - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Tinnitus - Pipeline Review, H1 2016’, provides an overview of the Tinnitus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tinnitus, complete with analysis by stage of development, drug targe...
$ 2,000.00 Read More

Traveler's Diarrhea - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Traveler's Diarrhea - Pipeline Review, H1 2016’, provides an overview of the Traveler's Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Traveler's Diarrhea, complete with analysis...
$ 2,000.00 Read More

Anxiety Disorders - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2016’, provides an overview of the Anxiety Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anxiety Disorders, complete with analysis by stage...
$ 2,000.00 Read More

Dyskinesia - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Dyskinesia - Pipeline Review, H1 2016’, provides an overview of the Dyskinesia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dyskinesia, complete with analysis by stage of development, drug...
$ 2,000.00 Read More

Actinic (Solar) Keratosis - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Actinic (Solar) Keratosis - Pipeline Review, H1 2016’, provides an overview of the Actinic (Solar) Keratosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Actinic (Solar) Keratosis, complet...
$ 2,000.00 Read More
Total 3022 records.